Home/TRexBio/Laura Berner, JD, MBA

LB

Laura Berner, JD, MBA

Chief Operating Officer

Therapeutic Areas

Immunology Oncology Dermatology Gastroenterology

TRexBio Pipeline

Drug	Indication	Phase
TRB-061	Atopic dermatitis (and other inflammatory diseases)	Phase 1

Leadership Team at TRexBio

Chief Executive Officer

Brandon Hants, MBA

Chief Financial Officer

Ariella Kelman, MD

Chief Medical Officer

Ali Zarrin, PhD

Chief Scientific Officer

View full TRexBio profile